• Esco Medical Technologies has opened its new plant in Lithuania, a pivotal EU manufacturing hub increasing production capabilities.

• The €10.6 million facility features an ergonomic design for optimal production flow.

• R&D and product management are co-located in the plant to facilitate collaboration and accelerate innovation.

• The plant will host training, seminars, and working sessions for service engineers, distributors, and prospective clients.

LITHUANIA, 24 September 2024 – Esco Medical Technologies (“EMT”), a subsidiary of Esco Lifesciences Group, has launched operations at its new plant in Lithuania, located in the Kaunas Free Economic Zone. The two-story facility spans 7,900 sqm—over twice the size of its previous plant—enabling expanded capacity and speed.

With R&D and product management in the same facility as manufacturing, EMT aims to drive innovation and strengthen product development.

The plant now houses around 80 employees and includes showrooms, meeting rooms, and seminar spaces. It features large windows, air conditioning, showers, a canteen, and an upcoming wellness room, plus bus transport and weekly sponsored lunches. Committed to sustainability, it has bird protection measures, EV parking, and A++ energy efficiency compliance.

“Our new EMT plant is now a key manufacturing and shared-services hub in the EU, strengthening market presence and fostering innovation. This demonstrates our commitment to customers and employees. We’re excited to see how this drives Esco Lifesciences Group’s mission in the EU and beyond,” said XQ Lin, CEO of Esco Lifesciences Group.